Scholay

学术搜索 · AI 审稿 · LaTeX 协作

Carlos Mena‐Hurtado

机构:Yale New Haven Hospital, Yale University · ORCID:0000-0002-4954-5672

发表论文 311 篇 · 总被引 4706 次 · h-index 29

代表论文

  • Medical Management and Revascularization for Asymptomatic Carotid Stenosis (2025 · New England Journal of Medicine · 被引 90)
  • Lower risk of cardiovascular events in patients initiated on semaglutide 2.4 mg in the real‐world: Results from the SCORE study (Semaglutide Effects on Cardiovascular Outcomes in People with Overweight or Obesity in the Real World) (2025 · Diabetes Obesity and Metabolism · 被引 12)
  • Periprocedural outcomes of embolic protection device use in carotid artery stenting (2025 · Journal of Vascular Surgery · 被引 3)
  • Pre-admission Opioid Use and Associated Outcomes in Patients Revascularised for Lower Peripheral Artery Disease (2025 · European Journal of Vascular and Endovascular Surgery · 被引 2)
  • Lower Risk of Cardiovascular Events in Patients With Clinical Atherosclerotic Cardiovascular Disease Who Initiated Semaglutide 2.4 mg in the Real‐World: Results From the SCORE—Clinical ASCVD Study (2026 · Diabetes Obesity and Metabolism · 被引 1)
  • Association between semaglutide 2.4 mg and risk of cardiovascular events in people with overweight or obesity without atherosclerotic cardiovascular disease in the real-world: The SCORE – primary prevention study (2026 · American Journal of Preventive Cardiology · 被引 1)